Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001014523 | SCV001175241 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002068888 | SCV002457491 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2023-11-17 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004792615 | SCV005405036 | benign | Familial cancer of breast | 2024-09-03 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Leiden Open Variation Database | RCV001194769 | SCV001364552 | uncertain significance | not provided | 2019-08-13 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Yukihide Momozawa. |